• A case-control study of polychlorinated biphenyl association with metabolic and hormonal outcomes in polycystic ovary syndrome
• A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D
• A Cross-Sectional Study of Alzheimer-Related Proteins in Women with Polycystic Ovary Syndrome
• A Cross-Sectional Study of Glomerular Hyperfiltration in Polycystic Ovary Syndrome
• A Cross-Sectional Study of Protein Changes Associated with Dementia in Non-Obese Weight Matched Women with and without Polycystic Ovary Syndrome
• A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
• A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome
• Acute frailty services: results of a national day of care survey
• Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome
• Analysis of 52 C₁₉ and C₂₁ steroids by UPC²-MS/MS: Characterising the C11-oxy steroid metabolome in serum
• Androstenedione and testosterone levels correlate with in vitro fertilization rates in insulin-resistant women
• Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome
• Anti-Mullerian hormone measurement for the diagnosis of polycystic ovary syndrome
• ASPIRE-3-PREVENT: a cross-sectional survey of preventive care after a coronary event across the UK
• Assessing the androgenic and metabolic heterogeneity in polycystic ovary syndrome using cluster analysis
• Association of Complement-Related Proteins in Subjects With and Without Second Trimester Gestational Diabetes
• Association of Vitamin D with Perfluorinated Alkyl Acids in Women with and without Non-Obese Polycystic Ovary Syndrome
• Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
• British Society of Gastroenterology position statement on serrated polyps in the colon and rectum
• Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
• Circulating Endothelial Microparticles Reduce in Concentration Following an Exercise Programme in Women With Polycystic Ovary Syndrome
• Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D
• Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
• Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity
• Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK
• Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
• Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
• Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
• Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
• COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
• COVID-19 Transmission in a Psychiatric Long-Term Care Rehabilitation Facility: An Observational Study
• COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis
• Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
• CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis
• Development of a novel risk prediction and risk stratification score for polycystic ovary syndrome
• Dynamic Change in Insulin Resistance Induced by Free Fatty Acids Is Unchanged Though Insulin Sensitivity Improves Following Endurance Exercise in PCOS
• Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women
• Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women
• Effect of pharmacological interventions on lipid profiles and C-reactive protein in polycystic ovary syndrome: A systematic review and meta-analysis
• Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study
• Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome
• Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss
• Evaluation the efficacy and safety of N-acetylcysteine inhalation spray in controlling the symptoms of patients with COVID-19: An open-label randomized controlled clinical trial
• Exploration of the correlation of serum polychlorinated biphenyl levels with luteal phase hormonal parameters and infertility in women with or without polycystic ovary syndrome
• Expression of microRNA in follicular fluid in women with and without PCOS
• HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study
• High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
• Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19
• Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
• Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials
• Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
• Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials
• Impaired heat shock protein 72 expression in women with polycystic ovary syndrome following a supervised exercise programme
• Improved physiology and metabolic flux after Roux-en-Y gastric bypass is associated with temporal changes in the circulating microRNAome: a longitudinal study in humans
• Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study
• Inflammatory Markers in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D Metabolites
• Influence of case definition on incidence and outcome of acute coronary syndromes
• Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
• Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjects
• Long COVID research: an update from the PHOSP-COVID Scientific Summit
• Long non-coding RNA expression in non-obese women with polycystic ovary syndrome and weight-matched controls
• Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review
• Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations
• Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
• Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight
• Metabolomics of Dynamic Changes in Insulin Resistance Before and After Exercise in PCOS
• microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
• miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review
• Neonatal presentation of PHACE syndrome
• Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D
• Perfluorinated alkyl acids in the serum and follicular fluid of UK women with and without polycystic ovarian syndrome undergoing fertility treatment and associations with hormonal and metabolic parameters
• Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
• Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome
• Regulation of circulating CTRP-2/CTRP-9 and GDF-8/GDF-15 by intralipids and insulin in healthy control and polycystic ovary syndrome women following chronic exercise training
• Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?
• Salivary and serum androgens with anti-Mullerian hormone measurement for the diagnosis of polycystic ovary syndrome
• Salivary testosterone measurement in women with and without polycystic ovary syndrome
• Self-esteem and body image satisfaction in women with PCOS in the Middle East: Cross-sectional social media study
• Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome
• The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review
• The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects
• The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome
• The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
• The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
• The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study
• The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
• The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
• The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controls
• The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies
• The impact of frailty and geriatric syndromes on metrics of acute care performance: results of a national day of care survey
• The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
• The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
• The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population
• The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
• Therapeutic Effect of Curcumin in Women with Polycystic Ovary Syndrome Receiving Metformin: A Randomized Controlled Trial
• Time Till Viral Clearance of Severe Acute Respiratory Syndrome Coronavirus 2 Is Similar for Asymptomatic and Non-critically Symptomatic Individuals
• Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index
• Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?
• Vitamin D association with the renin angiotensin system in polycystic ovary syndrome
• Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study